U.S. market projected to hit USD 246.85 Billion and Europe to reach USD 269.74 Billion by 2035 as advanced injectable and home-care delivery systems gain momentum. U.S. market projected to hit USD 246.85 Billion and Europe to reach USD 269.74 Billion by 2035 …
The GLP-1 Agonists Market offers growth opportunities due to rising diabetes cases, innovations in drug delivery, and personalized medicine. Strategic partnerships, especially in the Asia-Pacific, could capitalize on enhanced healthcare access. Challenges inc…
Advancements in Intranasal Drug Delivery and Rising Respiratory Illnesses Drive Rapid Adoption of Non-Invasive Therapeutic Formats. Advancements in Intranasal Drug Delivery and Rising Respiratory Illnesses Drive Rapid Adoption of Non-Invasive Therapeutic Form…
The controlled release drug delivery market is poised for growth driven by increased R&D, technological advances, and demand for convenient, effective chronic disease treatments. Key opportunities include aging populations, cost-efficient generics, and expand…